Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
National Cancer Institute
Welcome,
Profile
Billing
Logout
50 Products
275 Diseases
50 Products
77 Trials
6660 News
1
2
»
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
38
76
114
152
190
228
266
304
342
380
peripheral blood stem cell transplantation
/ National Cancer Institute
Yescarta
(axicabtagene ciloleucel) / Gilead
7-Hydroxystaurosporine
(UCN-01) / National Cancer Institute
ProstVac
(rilimogene galvacirepvec) / Bavarian Nordic
Young TIL
/ National Cancer Institute
sEphB4-HSA
/ VasGene, National Cancer Institute
rhIL-15
/ National Cancer Institute
LMB-100
/ National Cancer Institute
NY-ESO-1 TCR
/ Gilead
multi-epitope melanoma peptide
/ National Cancer Institute
LMB-2
/ National Cancer Institute
allogeneic K562-GM tumor cell vaccine
/ National Cancer Institute
SS1(dsFv)-PE38
/ AstraZeneca
E7 TCR cells
/ National Cancer Institute, Gilead
Ad-CCL21-DC
/ National Cancer Institute
CD19 CAR T cells
/ City of Hope, National Cancer Institute
Zonalta
(Z-endoxifen hydrochloride) / Jina Pharma, Intas
ropidoxuridine
(IPdR) / Shuttle Pharma, National Cancer Institute
dendritic cell-MART-1 peptide vaccine
/ National Cancer Institute
4'-Thio-2'-Deoxycytidine
(TdCyd) / National Cancer Institute
BiovaxID
(dasiprotimut-T) / National Cancer Institute, Accentia
CD19/CD22 CAR T-cells
/ National Cancer Institute
Combotox
(Imtox19/Imtox22) / Montefiore Medical Center, National Cancer Institute, Abiogen
FR Alpha Peptide Vaccine
/ National Cancer Institute
MAGE A3 TCR
/ Gilead, National Cancer Institute
Onyvax-P
(ONY-P) / GemVax & KAEL
TARP dendritic cell vaccine
/ PDS Biotech
anti-CD22 CAR T
/ National Cancer Institute
anti-CD3 x anti-CD20 bispecific antibody-armed activated T cells
/ National Cancer Institute
AGI-101H
/ National Cancer Institute
AdHER2/neu DC Vaccine
/ National Cancer Institute
BC8-SA
/ National Cancer Institute
CD123R(EQ)28zeta/EGFRt+ T cells
/ National Cancer Institute
EGFRvIII CAR
/ National Cancer Institute, Gilead
FCARH143
/ BMS, Fred Hutchinson Cancer Center, National Cancer Institute
FHVH-BCMA-T
/ National Cancer Institute
GM-CSF plasmid DNA melanoma vaccine
/ National Cancer Institute
H1299 cell lysate with iscomatrix adjuvant vaccine
/ National Cancer Institute
H1299 lung cancer cell lysate vaccine with Montanide ISA-51 VG adjuvant
/ National Cancer Institute
IL-12 engineered TIL
/ National Cancer Institute
IgG-RFB4-SMPT-dgA
/ National Cancer Institute
JCAR018
/ BMS, National Cancer Institute
LMP744
/ Gibson Oncology
MSLN CAR-T
/ National Cancer Institute
P30-EPS
/ Duke University, National Cancer Institute
Recombinant Vesicular Stomatitis Virus-expressing Interferon-beta and Tyrosinase Related Protein 1
/ National Cancer Institute
anti-CD33 CAR T
/ City of Hope, National Cancer Institute
anti-GD2 CAR-T cell therapy
/ Bellicum, National Cancer Institute
neoantigen peptide vaccine
/ Mayo Clinic, National Cancer Institute
rHIgM12B7
/ National Cancer Institute, Mayo Clinic
1
2
»
